GlassScriptPhysician profile
Cullen William Burke
NPI 1063778645
$1,624.18
in general payments reported to CMS, 2019-2025
17 companies · $92.99 in 2025
The $92.99 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $44.46 · 2021: $42.76 · 2022: $40.39 · 2023: $587 · 2024: $258 · 2025: $92.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $938.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $219.19 | 2019-2025 | Lybalvi, Aristada |
| Sunovion Pharmaceuticals INC. | $182.99 | 2019-2020 | |
| Axsome Therapeutics, INC. | $147.64 | 2023 | Auvelity |
| Abbvie INC. | $129.32 | 2021-2025 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $127.29 | 2019-2024 | Rexulti, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $119.53 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $117.49 | 2019-2023 | Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $107.04 | 2019-2025 | Ingrezza |
| Allergan, INC. | $105.86 | 2019 | |
| Corium, LLC | $100.37 | 2023-2024 | Azstarys |
| Janssen Pharmaceuticals, INC | $98.32 | 2019-2023 | Spravato |
| Lundbeck LLC | $63.66 | 2019-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $33.34 | 2020-2023 | Trintellix |
| Tris Pharma INC | $24.95 | 2023 | Dyanavel Xr |
| Shire North American Group INC | $17.17 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $16.94 | 2022 | |
| Avanir Pharmaceuticals, INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cullen Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.